Spotlights

Dr. Yossi Tam

PRINT Created with Sketch.
PRINT

Dr. Yossi Tam

PRINT Created with Sketch.
PRINT

Dr. Yossi Tam, D.M.D, Ph.D., heads the Obesity and Metabolism Laboratory at the Hebrew University’s Institute for Drug Research and is Director of the Multidisciplinary Center on Cannabinoid Research. The Multidisciplinary Center is focused on developing cannabinoid-based therapies to alleviate pain, treat traumatic brain injuries, and to address a broad spectrum of diseases. Dr. Tam, who works closely with Hebrew University Professor Emeritus Raphael Mechoulam, a world leader in the field of cannabis research, serves on the scientific board of Kalytera Therapeutics. Kalytera is developing cannabinoid-like and endocannaboid-like medicines for conditions ranging from osteoporosis to Prader-Willi Syndrome, a genetic disease.

Dr. Tam earned his Ph.D. at Hebrew University and received his D.M.D. from the Faculty of Dental Medicine. He launched his research in the area of bone biology, pursuing this work under the auspices of the Faculty of Dental Medicine and the School of Pharmacy. Dr. Tam explored the clinical phenomenon whereby traumatic brain injury induces a systemic stimulation of bone formation, leading to excessive accumulation of bone. Dr. Tam demonstrated a critical role for the eCB system in regulating bone mass, identifying a novel brain-to-bone pathway. His work was recognized with the prestigious Young Investigator Award by the American Society for Bone and Mineral Research.

Dr. Tam conducted his postdoctoral research fellowship in the U.S. at the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health (NIH), where he examined the biological mechanisms underlying obesity and metabolic syndrome. His research demonstrated the therapeutic potential of the first peripherally restricted, potent and selective CB1 blockers in biological models of obesity/metabolic syndrome. His preclinical findings showed that this class of compounds had strong clinical promise for treating obesity.

Dr. Tam joined the Hebrew University in 2014. His recent research investigates the peripheral eCB system in the development of obesity. His laboratory uses multidisciplinary approaches to study the molecular mechanisms involved in the development of metabolic syndrome. He has won numerous awards for his pioneering work, among these the Jacob Metzner’s Young Investigators Award and the FARE Award from the NIH.

SHARE

RELATED ARTICLES

Virginia Tech and Hebrew University of Jerusalem to...

Virginia Tech and Hebrew University of...

READ MORE

A Pioneering Partnership in Nanomedicine

A Pioneering Partnership in Nanomedicine

READ MORE

Hebrew University and University of Maryland Sign...

Hebrew University and University of...

READ MORE

Zuckerman Scholars Program

Zuckerman Scholars Program

READ MORE

HU and Freie Universität Berlin Expand Strategic...

HU and Freie Universität Berlin Expand...

READ MORE

Thomas Jefferson University and HU’s Faculty of...

Thomas Jefferson University and...

READ MORE

German and Israeli research leaders launch Global...

German and Israeli research leaders...

READ MORE

Latin American academic leaders sign cooperation agreements...

Latin American academic leaders sign...

READ MORE
X WHITE Copy Created with Sketch. X
Lightbox Increment Created with Sketch.
Arrow NEXT-image Created with Sketch.